Top compounds associated with response to MASTL


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 4e-06
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 5e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 6e-05
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 8e-05
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.14 9e-05
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC -0.12 0.0001
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA PD318088 CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
Download CSV